Navigation Links
$2.8 million grant boosts cystic fibrosis research at Queen's
Date:2/4/2011

Scientists at Queen's University Belfast have begun work into improving the lives of thousands of Cystic Fibrosis sufferers thanks to the award of a 1.74 million US-Ireland Research and Development Partnership grant.

The grant has been approved by the National Institutes of Health (NIH) in the USA with funding for the Queen's component provided by Health and Social Care Research and Development (HSC R&D Public Health Agency), Northern Ireland and the Medical Research Council. The grant is the largest ever to be awarded in the UK to study the microbiology of Cystic Fibrosis pulmonary infection.

The study is a collaborative US-Ireland international study with researchers in the Royal College of Surgeons Ireland, Dublin, the University of North Carolina at Chapel Hill, USA and the School of Pharmacy and the Centre for Infection and Immunity at Queen's University, Belfast.

Leading the study, Professor Stuart Elborn, Director of the Centre for Infection and Immunity in the School of Medicine, Dentistry and Biomedical Sciences at Queen's said; "The key goals of this study are to find out the role of anaerobes in causing damage to the lungs of people with Cystic Fibrosis. Anaerobes are bacteria that do not need oxygen to survive and we will determine whether their presence in the lung contributes to infection there.

We will also examine whether the bacteria are able to produce chemicals that can damage lung tissue and break down antibiotics given to treat lung infection. We will also look at how effective different antibiotics are in treating them."

He added; "The results of the study will be of important clinical relevance to people with Cystic Fibrosis because if we show that these anaerobes are contributing to infection and inflammation in the lungs of Cystic Fibrosis patients, in the future, patients could potentially be given more appropriate and effective antibiotics which should improve their clinical outcome and quality of life."

The research project has been funded for five years with an aim of recruiting a total of 450 Cystic Fibrosis patients across the three sites. The work will be performed in the 'US-Ireland Anaerobe Laboratory' in the Medical Biology Centre which has been recently refurbished - specifically to facilitate the delivery of this project.


'/>"/>

Contact: Claire O'Callaghan
c.ocallaghan@qub.ac.uk
44-289-097-5391
Queen's University Belfast
Source:Eurekalert

Related medicine news :

1. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
2. UofL Area Health Education Centers faculty, students make $6.8 million economic impact
3. Philanthropist invests $3.5 million in Buck Institutes Alzheimers drug development effort
4. 6 million euros for European Diabetes Research Network
5. 105 Million in U.S. Have Diabetes or Prediabetes, CDC Says
6. McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world
7. Khalifa Foundation grants MD Anderson $150 million for cancer research
8. LSTM leads new £6 million ($9.3 million) health systems knowledge consortium
9. NARSAD announces $12.6 million for new generation of brain and behavior research
10. Violence against mothers linked to 1.8 million female infant and child deaths in India
11. U.S. Spending Millions to See if Herbs Truly Work
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Switzerland (PRWEB) , ... April 24, 2017 , ... ... steps to become familiar. This makes it difficult for lab operators and management ... systematic methodology to help them identify wasteful or unnecessary actions. , Created ...
(Date:4/24/2017)... ... 2017 , ... “Reflections of God’s Work”: an enlightening collection of life lessons ... creation of published author, Jerri Broglin, a survivor of great loss who gained insight ... great eye-opener for those searching for answers, as we are finding the answers that ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), ... ANCD BRAIN device as the product advances towards regulatory and clinical phases. , ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura Communication Solutions, a ... Cisco Select certification and SMB specialization. Altura is now qualified to sell, ... earning the Select Certification, Altura fulfilled the training and exam requirements for the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology: